13 March 2025 - Leniolisib is the first ever treatment for activated phosphoinositide 3-kinase delta syndrome licensed for use in the ...
13 March 2025 - Today we've recommended the first long-term daily pill to treat endometriosis that could transform how this painful ...
12 March 2025 - NICE is unable to make a recommendation on the use of atezolizumab (Tecentriq) in the NHS for ...
12 March 2025 - NICE has published final evidence-based recommendations on the use of zolbetuximab (Vyloy) in combination with chemotherapy ...
12 March 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
6 March 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
6 March 2025 - Cost and evidence gaps remain barriers to approving funding in the NHS for donanemab and lecanemab. ...
5 March 2025 - The Department of Health and Social Care has asked the NICE to produce guidance on the ...
5 March 2025 - NICE has produced additional draft guidance on the use of idebenone in the NHS in England. ...
4 March 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
26 February 2025 - NICE has published final evidence-based recommendations on the use of exagamglogene autotemcel (Casgevy) for the treatment ...
26 February 2025 - NICE has published final evidence-based recommendations on the use of osimertinib mesylate (Tagrisso) for the adjuvant ...
20 February 2025 - Final guidance published today recommends lisocabtagene maraleucel (Breyanzi; Bristol Myers Squibb) as an option for treating ...
19 February 2025 - Conducting high quality health technology assessments requires high quality evidence. With evolving regulatory standards for faster approval ...
19 February 2025 - Surrogate endpoints, used to substitute for and predict final clinical outcomes, are increasingly being used to support ...